Dates:
Competition closes: 16th October 2024, 12pm
Invite to Interview: 13th December 2024
Interview panel: 6th-10th January 2025
Applicants notified: 21st January 2025
Project start date & duration: by 1st May 2025, 6-36 months
Scope – Your project can focus on (non-exhaustive)
- disease prevention and proactive management of health and chronic conditions
- earlier and better detection and diagnosis of disease, leading to better patient outcomes
- tailored treatments that either change the underlying disease or offer potential cures
- transforming the delivery of healthcare
- the development of digital health technologies
- consumer focused self-care
Your project can include; experimental evaluation (at laboratory scale), use of in vitro and in vivo models to evaluate proof of concept or safety, exploring potential production mechanisms, prototyping, product development planning, intellectual property protection, a demonstration of clinical utility and effectiveness, a demonstration of safety and efficacy (including phase 1 and phase 2 clinical trials), regulatory planning.
Specific Themes – Focus on any health/healthcare sector including (non-exhaustive)
- advanced therapies (including gene and cell therapies)
- biosciences
- preclinical technologies and drug target discovery
- therapeutic and medicine development
- diagnostics,
- medical technology and devices
- precision medicine
- digital health
- independent living
Eligibility
- Project must be led by a UK registered micro or small business (SME) and can be single-applicant or collaborative in nature.
- SMEs can lead only 1 application but can be a collaborator in 2 further applications.
- Collaborators can be UK registered orgnaisation of any size.
- R&D work must be carried out in the UK and project results exploited from UK.
- Subcontractors, preferably UK based, with costs justified and appropriate to the total project costs.
Funding Rates
Total project costs between £150K-£4Mn, with grant request not exceeding £2Mn. At least 50% of total project costs must be shared by SMEs, if collaborative. Grant request >£500K subject to interview stage.
| Project maturity (up to but not including commercialisation) | ||
| Organisation size | Industrial Research | Experimental Development |
| Micro/small business | <70% | <45% |
| Medium sized business | <60% | <35% |
| Large business | <50% | <25% |
Research organisations within the project team can share up to 50% of total project costs.
How PNO can support you
The UK team has a strong track record in securing some of the most competitive national and European grants on behalf of its clients, with a full understanding of how a project should be presented to stand the highest chance of success. Each year in the UK, we are responsible for the submission of >100 funding applications across all sectors and priority areas. Based on this extensive experience, through careful project selection and using key insight into how a project should be best positioned, we consistently achieve success rates that are more than 5 times the typical success rates for UK national schemes and EU programmes.
For further information or to discuss a project idea please contact PNO Consultants
0161 488 3488 | info.uk@pnoconsultants.com | https://www.pnoconsultants.com/uk/
